Our Mission
Advancing Cancer Diagnostics, Improving Lives
Our Vision
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Leica Biosystems Expands Research Digital Pathology Portfolio with Launch of the compact Aperio CS5 Scanner
VISTA, California, January 27, 2026 – Leica Biosystems, a Danaher company and global leader in anatomic and digital pathology solutions, announces the launch of the Aperio CS5 scanner, a compact device designed to support digital transformation in research pathology.
Leica Biosystems Unveils its Compact Capacity, Feature-Rich Digital Pathology Scanner at Asia Pacific Summit
VISTA, California – August 5, 2025 — Reinforcing its leadership in digital pathology for cancer diagnostics and research, Leica Biosystems proudly unveiled its Aperio GT 180 scanner at the Asia Pacific Imaging Summit 2025 — 9th Digital Pathology & AI Congress. Building on more than 25 years of…
Danaher and Leica Biosystems Announce Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics
Leica Biosystems at a Glance
150+ Years of Innovation
| 2012 - Present | New Era of Science & Technology |
| 2005 - 2011 | Global Expansion Accelerates |
| 1989 - 2004 | Structuring for Comprehensive Workflow |
| 1930 - 1988 | Novel Products Drive Company Growth |
| 1900 - 1930 | Microtomy Technology Advances Amidst Wartime Realities |
| 1872 - 1899 | The Creation of the Microtome and the Early Years of R. Jung GMBH |
About Danaher
Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.